Analyst Price Target is $161.17
▲ +142.57% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for iRhythm Technologies in the last 3 months. The average price target is $161.17, with a high forecast of $273.00 and a low forecast of $78.00. The average price target represents a 142.57% upside from the last price of $66.44.
Current Consensus is
The current consensus among 12 polled investment analysts is to hold stock in iRhythm Technologies. This Hold consensus rating has held steady for over two years.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.